Post-Transplant Vaccination with a Personalized Dendritic Cell/AML Fusion Cell Vaccine for Prevention of Relapse

Allogeneic transplantation is uniquely curative for a subset of patients with acute myeloid leukemia (AML) however, post-transplant relapse and graft versus host disease remain significant concerns. We have developed a vaccine in which patient-derived AML cells are fused with donor-derived dendritic...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2021-11, Vol.138 (Supplement 1), p.2830-2830
Hauptverfasser:	Liegel, Jessica J., Bindal, Poorva, Stone, Richard M., Soiffer, Robert J., Stroopinsky, Dina, Cheloni, Giulia, Bisharat, Lina, Torres, Daniela, Rahimian, Maryam, Yoo, Seo Yeon, Logan, Emma K., Elavalakanar, Pavania, El Banna, Hassan, Hauser, Joshua, Koshy, Anita G., Romee, Rizwan, Ho, Vincent T., Neuberg, Donna S., Liu, Yiwen, Mendez, Lourdes M., Dias, Ajoy L., Ebert, Benjamin L., Kufe, Donald, Avigan, David, Rosenblatt, Jacalyn
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!